Notice for Methotrexate (Lacuna Pharma Pty Ltd)
Active ingredients
Methotrexate
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Oral Solution
Indication
For the treatment of Acute Lymphoblastic Leukaemia (ALL)
Therapeutic area
Haematology